Skip to main content

Aberdeen Group plc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1716774 EDINBURGH, X0

Position in NBIX

as of Mar 31, 2026 · filed Apr 29, 2026
Position Value
$2,279,101
-$3,396,367 QoQ
Shares Held
17,300
-56.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $249,167,464 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NBIX
Neurocrine Biosciences Inc
This page
17,300 $2,279,101

All Filings in NBIX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,279,101 17,300
2025-12-31 $5,675,468 40,016
2025-09-30 $12,640,516 90,045
2025-06-30 $14,867,367 118,286
2025-03-31 $24,370,046 220,344
2024-12-31 $21,372,351 156,574
2024-09-30 $15,718,773 136,424
2024-06-30 $22,185,106 161,147
2024-03-31 $11,476,598 83,212
2023-12-31 $11,019,483 83,633
2023-09-30 $361,462 3,213
2023-06-30 $328,352 3,482
2023-03-31 $200,213 1,978
2021-03-31 $332,497 3,419
2020-12-31 $303,269 3,164
2020-09-30 $270,978 2,818
2020-06-30 $622,322 5,101
2020-03-31 $7,059,190 81,562